Equibles does not estimate personal net worth.
Get an email with a short summary when TriSalus Life Sciences, Inc. publishes a filing, an earnings call transcript or a press release.
Get TLSI alertsDavid Patience is recorded as CFO at TriSalus Life Sciences, Inc. (TLSI) since July 1, 2025. The newest filing on record that lists David Patience as CFO at TriSalus Life Sciences, Inc. (TLSI) is dated March 31, 2026. TriSalus Life Sciences, Inc. reported in an 8-K filed May 30, 2025 that David Patience was appointed Chief Financial Officer, effective July 1, 2025. The proxy statement of TriSalus Life Sciences, Inc. reports total compensation of $3,443,628 for David Patience in fiscal 2025, including a base salary of $268,462. Disclosed compensation is on record for 2 fiscal years. David Patience has spoken on 1 earnings call and 1 other investor event across 1 company, most recently for TriSalus Life Sciences, Inc. on September 14, 2026. TriSalus Life Sciences, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at TriSalus Life Sciences, Inc. includes Mary Szela (CEO and Board Member), Karim Karti (Chairman), Mats Wahlström (Chairman and Board Member) and 7 others.
“On May 27, 2025, the Company entered into an offer letter with David Patience for the position of Chief Financial Officer.”
“Yeah, as we scale the operation, you know, we have a near-term focus on bringing out new products.”
“I'm truly excited to join TriSalus Life Sciences at such an inflection point in the commercial trajectory of TriNab. As we build on this momentum, I've committed to seizing growth opportunities while maintaining the financial discipline needed to achieve near-term cash flow positivity.”
2025-07-01–present
Last confirmed March 31, 2026
Medical Devices · Healthcare
CFO
2025-07-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | TriSalus Life Sciences, Inc. (TLSI) | Chief Financial Officer(\ ) | $268,462 | $3,443,628 |
| 2024 | TriSalus Life Sciences, Inc. (TLSI) | Chief Financial Officer(\ ) | — | — |
